Idexx Laboratories | Les Charges D'Exploitation



Operating Expenses Changement Date
Abbott USD 9.06B 298M 2024-12
Align Technology USD 851.07M 35.5M 2024-12
Dentsply International USD 1.41B 1000K 2024-12
Dexcom USD 924.6M 82.4M 2024-12
Edwards Lifesciences USD 1.07B 69.4M 2024-12
Fujifilm JPY 725.1B 32.77B 2024-12
Globus Medical USD 597.02M 19.41M 2024-12
Henry Schein USD 3.04B 19M 2024-12
Hologic USD 792M 34M 2024-12
Idexx Laboratories USD 692.6M 20.95M 2024-12
Insulet USD 488.2M 32.4M 2024-12
Integra LifeSciences USD 407.42M 18.45M 2024-12
Intuitive Surgical USD 1.68B 882M 2024-12
Masimo USD 959.8M 485.3M 2024-12
Neogen USD 215.56M 473.18M 2025-02
Patterson Companies USD 1.53B 109.77M 2025-01
ResMed USD 864.85M 27.65M 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Steris USD 1.13B 9.69M 2024-12
Tandem Diabetes Care USD 283.23M 13.17M 2024-12
Teleflex USD 905.79M 290.73M 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12
Zoetis USD 1.59B 71M 2024-12



Idexx Laboratories Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.